About me
Greg Gierer is a health policy expert with more than 20 years of experience in Washington, DC with demonstrated success in advocating before the Congress, federal agencies, state governments and policymakers. He has expertise in the federal legislative and regulatory policy process and success in achieving positive outcomes for healthcare organizations, including through the development and implementation of policy and advocacy strategies.
His areas of expertise include the Affordable Care Act; comprehensive health care reform; Medicare policy, including Medicare Advantage and Part D; prescription drug policy and drug pricing reforms; and health system and payment reforms.
Before joining Health Management Associates, Greg was vice president of Policy and Research at the Better Medicare Alliance (BMA), the leading non-profit research and advocacy organization focused on strengthening and improving the Medicare Advantage (MA) program. During his tenure at BMA, Greg led regulatory policy development and engagement with the Centers for Medicare & Medicaid Services (CMS) to advance BMA’s policy and advocacy priorities.
Prior to joining BMA, Greg was the senior vice president for Policy at AHIP where he led regulatory policy work and strategy related to the Affordable Care Act (ACA) implementation, including the successful implementation of the ACA exchanges and insurance market reform regulations. Later, Greg led policy-development work to advance public policies to strengthen and stabilize the exchange marketplace.
Previously, Greg held senior public policy roles at the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Blue Cross and Blue Shield Association. He started his career on Capitol Hill as a legislative aide to Senator Chris Dodd (D-CT).
Informing his policy and advocacy efforts, Greg has extensive experience developing and managing research and consulting projects. Under his direction, BMA partnered with leading research organizations and consulting firms to produce timely, rigorous, and credible research and analysis reports that demonstrate the value of MA to beneficiaries. Greg is also a skilled communicator and nationally recognized thought-leader who has represented numerous healthcare organizations and associations at high-profile health policy and business conferences.
